Adlai Nortye ANL
NASDAQ ANL
$10.82 +0.86 (+8.66%)
As of: Nov 11, 2026 · 2:55 PM EST

Adlai Nortye (ANL) Total Debt (2022 - 2026)

Updated

Adlai Nortye (ANL) posted Total Debt of $24.96 million for Q2 2026, down 43.3% from $44.05 million a year earlier.

Analysis

Adlai Nortye (ANL) Total Debt (2022 - 2026) Analysis & Trends

At the end of FY2025, Adlai Nortye's Total Debt came in at $24.58 million, down 6.6% from FY2024.

  • Annual Total Debt has declined for three consecutive years, with a three-year compound annual growth rate of -56.3% (FY2022 to FY2025).
  • In prior years, Adlai Nortye's Total Debt was $26.33 million in FY2024 (-13.3%), $30.36 million in FY2023 (-89.7%) and $294.68 million in FY2022.
  • Quarterly Total Debt has run from a low of -$602,000 in Q4 2023 to a high of $290.08 million in Q4 2022 over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 49.50 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 44.65 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 80.90 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 53.78 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -6.68 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 54.01 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 26.23 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 62.67 Bn
10 Adlai Nortye 342.00 Mn -2.99 Mn - 24.96 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 24.96 Mn
Dec 31, 2025 24.58 Mn
Jun 30, 2025 44.05 Mn
Dec 31, 2024 26.33 Mn
Dec 31, 2023 30.36 Mn
Dec 31, 2022 4.31 Mn
API Access

Adlai Nortye Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=ANL&period=max&api_key=YOUR_API_KEY